◀ Back to ALB
ALB — CRP
Text-mined interactions from Literome
Iseki et al., Nephrol Dial Transplant 1999
:
CRP is a significant predictor of death in chronic dialysis patients,
independent of serum
albumin and other possible confounders
Kalender et al., Int J Clin Pract 2002
(Anemia) :
In the present study, the
effects of
C-reactive protein (CRP) and ferritin on serum
albumin , transferrin and haemoglobin ( Hb ) were assessed to investigate the relationship between inflammation, hypoalbuminaemia and anaemia in haemodialysis patients
Jones et al., J Ren Nutr 2002
(Body Weight...) :
In multivariate analysis, predialysis
albumin was dependent on nPCR ( P =.04 ), CRP ( P < .0001 ), and predialysis Vecf % Vtbw ( P =.002 ), and postdialysis albumin was
dependent on nPCR ( P =.01 ),
CRP ( P =.002 ), and postdialysis Vecf % Vtbw ( both P < .0001 )
Vernaglione et al., Am J Kidney Dis 2004
(Cardiovascular Diseases) :
Administration of atorvastatin is safe in patients on long-term HD therapy and, in addition to its beneficial effects on lipid levels,
induces a significant decrease in serum
CRP levels, with a consequential increase in serum
albumin levels
Chazot et al., Kidney Int 2013
:
The Monitoring Dialysis Outcomes ( MONDO ) database shows that in 40,000 dialysis patients worldwide who died, systolic blood pressure, interdialytic weight gain, and serum
albumin declined progressively, and
C-reactive protein increased more than 12 months before death, indicating that predictive models may be developed to enable nephrologists to improve the clinical outcome of dialysis patients